Jazz Pharmaceuticals Ownership | Who Owns Jazz Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Jazz Pharmaceuticals Ownership Summary


Jazz Pharmaceuticals is owned by 91.44% institutional investors, 3.09% insiders, and 5.47% retail investors. Vanguard group is the largest institutional shareholder, holding 9.83% of JAZZ shares. Pacer US Cash Cows 100 ETF is the top mutual fund, with 3.55% of its assets in Jazz Pharmaceuticals shares.

JAZZ Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockJazz Pharmaceuticals91.44%3.09%5.47%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%
IdeaCannabis Stocks List16.74%11.80%71.46%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group6.04M9.83%$743.36M
Blackrock6.15M9.83%$655.94M
Blackrock funding, inc. /de5.85M9.53%$720.58M
Lsv asset management2.53M4.12%$311.70M
Pacer advisors2.21M3.61%$272.71M
Dimensional fund advisors lp2.04M3.31%$250.62M
State street2.02M3.23%$215.31M
Capital world investors1.92M3.13%$236.86M
Ameriprise financial1.83M2.98%$225.08M
Ecor1 capital1.71M2.78%$210.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Estuary capital management lp232.52K8.37%$28.63M
Ecor1 capital1.71M7.95%$210.15M
Vestal point capital, lp975.00K7.12%$120.07M
Polaris capital management1.09M6.45%$133.72M
Darwin global management484.51K5.65%$59.67M
Krensavage asset management109.08K5.35%$11.64M
Sofinnova investments504.19K4.52%$62.09M
Tri locum partners lp161.81K4.13%$19.93M
Camber capital management lp1.15M3.28%$141.62M
Gmt capital508.80K3.05%$62.66M

Top Buyers

HolderShares% AssetsChange
Fuller & thaler asset management939.35K0.44%507.23K
Darwin global management484.51K5.65%484.51K
Dimensional fund advisors lp2.04M0.06%320.72K
Sofinnova investments504.19K4.52%315.63K
Ameriprise financial1.83M0.06%315.61K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---1.27M
Blackrock6.15M0.01%-924.16K
Rubric capital management lp---616.62K
Franklin resources658.75K0.02%-459.94K
State street2.02M0.01%-444.83K

New Positions

HolderShares% AssetsChangeValue
Darwin global management484.51K5.65%484.51K$59.67M
Alyeska investment group228.10K0.11%228.10K$28.09M
Logos global management lp175.00K2.52%175.00K$21.55M
Tri locum partners lp161.81K4.13%161.81K$19.93M
Cercano management112.37K0.35%112.37K$13.84M

Sold Out

HolderChange
Harbor investment advisory-1.00
Center for financial planning-1.00
Financial gravity asset management-2.00
Advisornet financial-2.00
Rfp financial group-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024468-2.50%56,158,556-2.64%911.04%238-155-1.27%
Sep 30, 20244732.83%57,472,0080.00%931.12%2357.31%155-6.06%
Jun 30, 2024456-6.37%57,467,965-0.65%911.10%218-6.84%1620.62%
Mar 31, 2024487-4.32%57,846,6723.04%911.16%234-0.85%161-10.56%
Dec 31, 20235093.25%56,141,8891.42%881.19%2367.76%1800.56%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Pacer US Cash Cows 100 ETF2.16M3.55%3.19K
iShares Core S&P Mid-Cap ETF1.97M3.25%3.47K
Capital Group Fundamental Invtrs Comp1.90M3.14%100.65K
American Funds Fundamental Invs A1.90M3.14%100.65K
Vanguard US Total Market Shares ETF1.84M3.03%-44.10K
Vanguard Total Stock Mkt Idx Inv1.81M2.97%1.00K
Vanguard Small Cap Index1.47M2.41%1.20K
Vanguard Small Cap Value Index Inv965.72K1.59%-3.44K
Vanguard Institutional Extnd Mkt Idx Tr919.90K1.51%3.90K
FullerThaler Behavioral Sm-Cp Eq R6897.66K1.48%487.58K

Recent Insider Transactions


DateNameRoleActivityValue
Apr 01, 2025COZADD BRUCE C Chairman & CEOSell$185.63K
Mar 10, 2025Iannone Robert EVP, Global Head of R&D & CMOSell$332.60K
Mar 10, 2025Carr Patricia SVP, Chief Accounting OfficerSell$157.10K
Mar 07, 2025Iannone Robert EVP, Global Head of R&D & CMOSell$764.58K
Mar 07, 2025Iannone Robert EVP, Global Head of R&D & CMOSell$216.72K

Insider Transactions Trends


DateBuySell
2025 Q2-1
2025 Q1-10
2024 Q4-4
2024 Q3-1
2024 Q2-2

JAZZ Ownership FAQ


Who Owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals shareholders are primarily institutional investors at 91.44%, followed by 3.09% insiders and 5.47% retail investors. The average institutional ownership in Jazz Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Jazz Pharmaceuticals exceeds.

Who owns the most shares of Jazz Pharmaceuticals?

Jazz Pharmaceuticals’s largest shareholders are Vanguard group (6.04M shares, 9.83%), Blackrock (6.15M shares, 9.83%), and Blackrock funding, inc. /de (5.85M shares, 9.53%). Together, they hold 29.18% of Jazz Pharmaceuticals’s total shares outstanding.

Does Blackrock own Jazz Pharmaceuticals?

Yes, BlackRock owns 9.83% of Jazz Pharmaceuticals, totaling 6.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 655.94M$. In the last quarter, BlackRock decreased its holdings by -924K shares, a -13.07% change.

Who is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Estuary capital management lp is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.37% of its assets in 232.52K Jazz Pharmaceuticals shares, valued at 28.63M$.

Who is the top mutual fund holder of Jazz Pharmaceuticals shares?

Pacer US Cash Cows 100 ETF is the top mutual fund holder of Jazz Pharmaceuticals shares, with 3.55% of its total shares outstanding invested in 2.16M Jazz Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools